Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | MIR92B | Human | 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of MIR92B mRNA | CTD | PMID:22403704 | MIR92B | Human | 17beta-estradiol | decreases expression | EXP | | 6480464 | Estradiol results in decreased expression of MIR92B mRNA | CTD | PMID:24877718 | MIR92B | Human | benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of MIR92B mRNA | CTD | PMID:22048643 | MIR92B | Human | bis(2-ethylhexyl) phthalate | multiple interactions | ISO | Mir92b (Mus musculus) | 6480464 | [ovalbumin-alum co-treated with Diethylhexyl Phthalate] results in increased expression of MIR92B | CTD | PMID:36508822 | MIR92B | Human | bisphenol A | increases methylation | ISO | Mir92b (Rattus norvegicus) | 6480464 | bisphenol A results in increased methylation of MIR92B gene | CTD | PMID:28505145 | MIR92B | Human | buta-1,3-diene | decreases expression | ISO | Mir92b (Mus musculus) | 6480464 | 1 and 3-butadiene results in decreased expression of MIR92B mRNA | CTD | PMID:29038090 | MIR92B | Human | cadmium atom | multiple interactions | ISO | Mir92b (Rattus norvegicus) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MIR92B mRNA | CTD | PMID:33652105 | MIR92B | Human | cadmium dichloride | multiple interactions | ISO | Mir92b (Rattus norvegicus) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MIR92B mRNA | CTD | PMID:33652105 | MIR92B | Human | cadmium dichloride | increases expression | ISO | Mir92b (Rattus norvegicus) | 6480464 | Cadmium Chloride results in increased expression of MIR92B mRNA | CTD | PMID:34662668 | MIR92B | Human | choline | multiple interactions | ISO | Mir92b (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of MIR92B mRNA | CTD | PMID:20548288 | MIR92B | Human | cisplatin | increases expression | ISO | Mir92b (Rattus norvegicus) | 6480464 | Cisplatin results in increased expression of MIR92B mRNA | CTD | PMID:27397436 | MIR92B | Human | DDT | decreases expression | EXP | | 6480464 | DDT results in decreased expression of MIR92B mRNA | CTD | PMID:22403704 | MIR92B | Human | folic acid | multiple interactions | ISO | Mir92b (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of MIR92B mRNA | CTD | PMID:20548288 | MIR92B | Human | L-methionine | multiple interactions | ISO | Mir92b (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of MIR92B mRNA | CTD | PMID:20548288 | MIR92B | Human | ochratoxin A | decreases expression | EXP | | 6480464 | ochratoxin A results in decreased expression of MIR92B mRNA | CTD | PMID:30428381 | MIR92B | Human | paracetamol | decreases expression | ISO | Mir92b (Rattus norvegicus) | 6480464 | Acetaminophen results in decreased expression of MIR92B mRNA | CTD | PMID:27397436 | MIR92B | Human | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of MIR92B mRNA | CTD | PMID:29067470 | MIR92B | Human | progesterone | increases expression | EXP | | 6480464 | Progesterone results in increased expression of MIR92B mRNA | CTD | PMID:22950660 | MIR92B | Human | resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of MIR92B mRNA | CTD | PMID:22016468 | MIR92B | Human | silver atom | increases expression | ISO | Mir92b (Mus musculus) | 6480464 | Silver results in increased expression of MIR92B mRNA | CTD | PMID:27131904 | MIR92B | Human | silver(0) | increases expression | ISO | Mir92b (Mus musculus) | 6480464 | Silver results in increased expression of MIR92B mRNA | CTD | PMID:27131904 | MIR92B | Human | sodium arsenite | decreases expression | EXP | | 6480464 | sodium arsenite results in decreased expression of MIR92B mRNA | CTD | PMID:32066060 | MIR92B | Human | sodium arsenite | multiple interactions | EXP | | 6480464 | sodium arsenite inhibits the reaction [SFPQ protein binds to MIR92B mRNA] | CTD | PMID:32066060 | MIR92B | Human | valproic acid | decreases expression | ISO | Mir92b (Mus musculus) | 6480464 | Valproic Acid results in decreased expression of MIR92B mRNA | CTD | PMID:24896083 | |